Pharmacovigilance Management Consulting FAQ’s

Management consulting examines how pharmacovigilance work is organised, governed and controlled. Day-to-day delivery involves performing the operational activities within that structure.

Pharmacovigilance Management Consulting focuses on improving the model behind delivery, including responsibilities, workflows and oversight. The aim is to make the function easier to manage and more consistent in practice.

Yes. An operating model can include internal specialists, external providers and regional teams. Its effectiveness depends on how clearly their activities, interfaces and oversight arrangements are defined.

A review can examine where responsibilities overlap, where information is lost and how decisions are escalated. The resulting model should reflect the organisation’s needs rather than assume that one sourcing approach suits every activity.

It can help review governance meetings, performance measures, escalation routes and the handling of recurring issues. It can also examine whether responsibilities are sufficiently clear across the relationship.

The objective is to make oversight useful for decision-making. Reports should help identify problems, assign action and evaluate progress, rather than simply record that a service review has taken place.

Yes. A review can clarify which decisions and processes should be coordinated centrally and where local input or variation is needed. It can also assess how information moves between teams.

Relevant developments identified through Regulatory Intelligence can inform this work. Clear documentation of local differences helps teams understand their responsibilities without creating unnecessary inconsistency.

Growth can increase workload, add interfaces and expose arrangements that previously depended on informal communication. Management consulting can assess whether responsibilities, resources and oversight are suited to the planned scale.

The review may consider future volumes, additional partners and more complex decision-making. Improvements can then be phased around business milestones rather than introduced only after delivery problems emerge.

It can help compare existing operating models, identify overlapping responsibilities and plan how teams and processes will work together. Particular attention may be needed at interfaces between systems, vendors and governance structures.

The scope should define which integration decisions need support. A phased plan can preserve operational continuity while the organisation works towards its intended model.

It can examine whether repeated issues share an underlying cause, such as unclear instructions, fragmented ownership or an ineffective handoff. This helps identify improvements beyond correcting each individual occurrence.

Where knowledge gaps contribute to the problem, Pharmacovigilance Training may support the response. Training should be combined with process changes when the weakness is structural.

Depending on scope, outputs may include a description of the current and proposed model, responsibility maps, workflow diagrams, governance arrangements and a prioritised implementation plan.

The deliverables should explain how the organisation will move from its current position to the proposed approach. Agree the level of detail, intended users and approval process before work begins.

Yes. Some improvements involve clearer ownership, better handoffs, revised meeting structures or more useful reporting. These may be possible within the existing technology environment.

A review should identify where system limitations genuinely affect delivery and where process changes may be sufficient. Technology recommendations should follow the evidence and the organisation’s requirements.

It turns organisational and operational priorities into changes in how work is managed. Pharmacovigilance Benchmarking can help identify the priorities, while training and regulatory intelligence can support implementation.

Within Qinecsa’s wider Pharmacovigilance Consulting services, these activities can be coordinated around a shared set of outcomes.